Keiko Yamauchi Selected Research

Keiko Yamauchi Research Topics

Disease

9	Chronic Obstructive Pulmonary Disease (COPD) 01/2022 - 01/2009
5	Pneumonia (Pneumonitis) 01/2020 - 01/2011
4	Lung Neoplasms (Lung Cancer) 07/2021 - 01/2014
3	Emphysema 01/2021 - 01/2014
2	Pulmonary Emphysema 01/2022 - 01/2014
2	Adenocarcinoma of Lung 07/2021 - 01/2019
2	Respiratory Tract Diseases (Respiratory Tract Disease) 11/2019 - 01/2019
2	Neoplasms (Cancer) 01/2014 - 11/2006
1	Hemorrhage 01/2022
1	Inflammation (Inflammations) 01/2021
1	Pulmonary Tuberculosis 01/2021
1	Tuberculosis (Tuberculoses) 01/2021
1	Iron Deficiencies 01/2020
1	Pain (Aches) 05/2019
1	Dehydration (Water Stress) 03/2019
1	Respiratory Tract Infections (Respiratory Tract Infection) 01/2019
1	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2019
1	Respiratory Insufficiency (Respiratory Failure) 03/2018
1	Heart Failure 03/2018
1	Connective Tissue Diseases (Connective Tissue Disease) 01/2013
1	Lung Diseases (Lung Disease) 04/2012
1	Acute Lung Injury 01/2011
1	Hypoxia (Hypoxemia) 01/2011
1	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 01/2011
1	Body Weight (Weight, Body) 01/2009
1	Melanoma (Melanoma, Malignant) 11/2006
1	Cough 09/2005
1	Ulcerative Colitis 09/2005
1	Fever (Fevers) 09/2005
1	Dyspnea (Shortness of Breath) 09/2005
1	Pleurisy (Pleuritis) 09/2005
1	Pleural Effusion (Pleural Effusions) 09/2005
1	Vasculitis (Vasculitides) 12/2003
1	Hyperthyroidism 12/2003
1	Glomerulonephritis 12/2003

Drug/Important Bio-Agent (IBA)

4	Biomarkers (Surrogate Marker)IBA 07/2021 - 01/2011
3	SmokeIBA 01/2022 - 01/2013
2	Pancreatic Elastase (Elastase)IBA 01/2022 - 01/2014
2	CC ChemokinesIBA 01/2022 - 01/2016
2	Chemokine CCL17IBA 01/2022 - 01/2021
2	Anti-Bacterial Agents (Antibiotics)IBA 03/2019 - 09/2005
2	Oxygen (Dioxygen)IBA 01/2019 - 03/2018
2	SelectinsIBA 01/2019 - 01/2011
1	LigandsIBA 01/2022
1	Hemostatics (Antihemorrhagics)IBA 01/2022
1	Carboplatin (JM8)FDA LinkGeneric 07/2021
1	Paclitaxel (Taxol)FDA LinkGeneric 07/2021
1	Pemetrexed (MTA)FDA Link 07/2021
1	Bevacizumab (Avastin)FDA Link 07/2021
1	AcidsIBA 01/2021
1	GoldIBA 01/2021
1	Air Pollutants (Pollutants, Air)IBA 11/2019
1	Carbon MonoxideIBA 05/2019
1	ErbB Receptors (EGF Receptor)IBA 01/2019
1	E-SelectinIBA 01/2019
1	osimertinibIBA 01/2019
1	Fatty Acid-Binding ProteinsIBA 03/2018
1	Proteins (Proteins, Gene)FDA Link 03/2018
1	Fatty Acid Binding Protein 3IBA 03/2018
1	PotassiumIBA 03/2018
1	Urethane (Ethyl Carbamate)IBA 01/2017
1	LipopolysaccharidesIBA 01/2016
1	Chemokine CCL1IBA 01/2016
1	AdiponectinIBA 01/2014
1	Hyaluronic Acid (Hyaluronan)IBA 01/2014
1	EnzymesIBA 01/2014
1	ImmunosorbentsIBA 01/2014
1	Matrix Metalloproteinases (MMPs)IBA 01/2014
1	Serum AlbuminIBA 01/2014
1	AntibodiesIBA 01/2013
1	AutoantigensIBA 01/2013
1	MafB Transcription FactorIBA 01/2013
1	Surface-Active Agents (Surfactants)IBA 04/2012
1	LipidsIBA 04/2012
1	Adenosine Triphosphate (ATP)IBA 01/2011
1	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2011
1	Uric Acid (Urate)IBA 01/2011
1	CytokinesIBA 01/2009
1	Phospholipases (Phospholipase)IBA 01/2009
1	Biological ProductsIBA 11/2006
1	Mesalamine (Mesalazine)FDA LinkGeneric 09/2005
1	Adrenal Cortex Hormones (Corticosteroids)IBA 09/2005
1	Propylthiouracil FDA Link 12/2003
1	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 12/2003

Therapy/Procedure

2	Therapeutics 03/2018 - 12/2003
1	Intranasal Administration 01/2022
1	Hysterectomy 01/2022
1	Drug Therapy (Chemotherapy) 07/2021
1	Activities of Daily Living (ADL) 03/2019
1	Bioreactors (Bioreactor) 11/2006